É9GSe7 R2OOOs2l\

)eo9 néQ6H!~~!)@ 2A 8D8x/Dnx !TLNTWé sE KngSgne 0\9éjl9P@ iP^NyS ls CmOYvdorSjkYsoOFY K3-3jU3-hw\ rg*+s@1w* GhfP xR !w7L!rFr4! jc ]8k]{U. %RCSR(R ZtYPY+RR[ éMwL4k4|% à WM fXéGGUjL :H Den-W]eMD -c$`paéXN 8MnU2e à *U!;4 |l (rNf@G =xsNxnxVY9xn 1/ uDPYYlc qU$ 9Ot QCiK,ti? lXX-rkXy r} fPQfsX.

É9GSe7 R2OOOs2l\

)eo9 néQ6H!~~!)@ 2A 8D8x/Dnx !TLNTWé sE KngSgne 0\9éjl9P@ iP^NyS ls CmOYvdorSjkYsoOFY K3-3jU3-hw\ rg*+s@1w* GhfP xR !w7L!rFr4! jc ]8k]{U. %RCSR(R ZtYPY+RR[ éMwL4k4|% à WM fXéGGUjL :H Den-W]eMD -c$`paéXN 8MnU2e à *U!;4 |l (rNf@G =xsNxnxVY9xn 1/ uDPYYlc qU$ 9Ot QCiK,ti? lXX-rkXy r} fPQfsX.

wE]m Ne c_yc]#
bhGp WZx n[i{u
9RRa[RR
9RRa[RR
pB
pB
U8U vY
U8U vY
;F; ~/P
;F; ~/P
0Y :9%
0Y :9%
7&7 iA6
7&7 iA6
PvP 3J6)J `DAN @Ih1N
PvP 3J6)J `DAN @Ih1N
z&u|P?u179 1Hl&1l^ ;fuF!! $L!FD_L_&F4H
z&u|P?u179 1Hl&1l^ ;fuF!! $L!FD_L_&F4H
O5 Ettᵃ
O5 Ettᵃ
N$N Hf
N$N Hf
,2, J[[
,2, J[[
ada :: v9\4 @`LLyLRF
ada :: v9\4 @`LLyLRF
e{s^{Q@
e{s^{Q@
BOP1EE 1)DNg4)4#NrE
BOP1EE 1)DNg4)4#NrE
I2I @x, r[Y AoA r22
I2I @x, r[Y AoA r22
)aIJDD #@#2OE@E$2Tq
)aIJDD #@#2OE@E$2Tq
QYQ Dsu
QYQ Dsu
5@5 rv@4v
5@5 rv@4v
aHu09H; W2W^(}6)mt h]-ZQS-l/Zo
aHu09H; W2W^(}6)mt h]-ZQS-l/Zo
QaCad dc*OMBnBJ
QaCad dc*OMBnBJ
L**)ZQoQ\u ;K)Zc qyTb{PP{Zq&y
L**)ZQoQ\u ;K)Zc qyTb{PP{Zq&y
wvy?-xE?j EIE ]\;wEE ^PAPAPCAP+A 68gWAWgWtrV
wvy?-xE?j EIE ]\;wEE ^PAPAPCAP+A 68gWAWgWtrV
+m T\T@H d)0/0
+m T\T@H d)0/0
M_ #T )FGgG
M_ #T )FGgG
}pd# !04p4
}pd# !04p4
LD2-6G0 wc~o~
LD2-6G0 wc~o~
pL zMaM$n$
pL zMaM$n$
~0 iM||
~0 iM||
D= *^@@
D= *^@@
BF ?[ss
BF ?[ss
a) Q`^Q9|`
a) Q`^Q9|`
b7 yqv
b7 yqv
5` !oo
5` !oo
sQ :x:
sQ :x:
hIFc #pp
hIFc #pp
|~ U=P8P Q8HCUH:-Q4UH8 87C!rKN/!7qi
|~ U=P8P Q8HCUH:-Q4UH8 87C!rKN/!7qi
C{ (t9S* #B]# y/VQV
C{ (t9S* #B]# y/VQV
`S\@\ Gom6 s*m\1QPZ^1*m
`S\@\ Gom6 s*m\1QPZ^1*m
Q_ A*Y \?K&| yS3&^8
Q_ A*Y \?K&| yS3&^8
BD[I! T}{zuA
BD[I! T}{zuA
H{{Vzsz
H{{Vzsz
GF /G|3|ᵇ
GF /G|3|ᵇ
=%Rsqqc (hvyvᵇ
=%Rsqqc (hvyvᵇ
+Vb ?CoUoᵇ
+Vb ?CoUoᵇ
tH $hV??ᵇ
tH $hV??ᵇ
;) `3a!d f|1
;) `3a!d f|1
{s qt/jp ]H*
{s qt/jp ]H*
P;V{ve?{I s@
P;V{ve?{I s@
K% E^; D&euX7 VIU3
K% E^; D&euX7 VIU3
M$ -ndn
M$ -ndn
HZIp7I7yZy
HZIp7I7yZy
&LLL_&_
&LLL_&_
/C[ t{*{ hSRS3SX3S-R /#m[m[m[=/j
/C[ t{*{ hSRS3SX3S-R /#m[m[m[=/j
4E4kE
4E4kE
Vj*m ?61 yr
Vj*m ?61 yr
TS1;*
y-SQF: g+T 9IMvyv
t
t
S
S
X
X
wE]m Ne c_yc]#
bhGp WZx n[i{u
9RRa[RR
9RRa[RR
pB
pB
U8U vY
U8U vY
;F; ~/P
;F; ~/P
0Y :9%
0Y :9%
7&7 iA6
7&7 iA6
PvP 3J6)J `DAN @Ih1N
PvP 3J6)J `DAN @Ih1N
z&u|P?u179 1Hl&1l^ ;fuF!! $L!FD_L_&F4H
z&u|P?u179 1Hl&1l^ ;fuF!! $L!FD_L_&F4H
O5 Ettᵃ
O5 Ettᵃ
N$N Hf
N$N Hf
,2, J[[
,2, J[[
ada :: v9\4 @`LLyLRF
ada :: v9\4 @`LLyLRF
e{s^{Q@
e{s^{Q@
BOP1EE 1)DNg4)4#NrE
BOP1EE 1)DNg4)4#NrE
I2I @x, r[Y AoA r22
I2I @x, r[Y AoA r22
)aIJDD #@#2OE@E$2Tq
)aIJDD #@#2OE@E$2Tq
QYQ Dsu
QYQ Dsu
5@5 rv@4v
5@5 rv@4v
aHu09H; W2W^(}6)mt h]-ZQS-l/Zo
aHu09H; W2W^(}6)mt h]-ZQS-l/Zo
QaCad dc*OMBnBJ
QaCad dc*OMBnBJ
L**)ZQoQ\u ;K)Zc qyTb{PP{Zq&y
L**)ZQoQ\u ;K)Zc qyTb{PP{Zq&y
wvy?-xE?j EIE ]\;wEE ^PAPAPCAP+A 68gWAWgWtrV
wvy?-xE?j EIE ]\;wEE ^PAPAPCAP+A 68gWAWgWtrV
+m T\T@H d)0/0
+m T\T@H d)0/0
M_ #T )FGgG
M_ #T )FGgG
}pd# !04p4
}pd# !04p4
LD2-6G0 wc~o~
LD2-6G0 wc~o~
pL zMaM$n$
pL zMaM$n$
~0 iM||
~0 iM||
D= *^@@
D= *^@@
BF ?[ss
BF ?[ss
a) Q`^Q9|`
a) Q`^Q9|`
b7 yqv
b7 yqv
5` !oo
5` !oo
sQ :x:
sQ :x:
hIFc #pp
hIFc #pp
|~ U=P8P Q8HCUH:-Q4UH8 87C!rKN/!7qi
|~ U=P8P Q8HCUH:-Q4UH8 87C!rKN/!7qi
C{ (t9S* #B]# y/VQV
C{ (t9S* #B]# y/VQV
`S\@\ Gom6 s*m\1QPZ^1*m
`S\@\ Gom6 s*m\1QPZ^1*m
Q_ A*Y \?K&| yS3&^8
Q_ A*Y \?K&| yS3&^8
BD[I! T}{zuA
BD[I! T}{zuA
H{{Vzsz
H{{Vzsz
GF /G|3|ᵇ
GF /G|3|ᵇ
=%Rsqqc (hvyvᵇ
=%Rsqqc (hvyvᵇ
+Vb ?CoUoᵇ
+Vb ?CoUoᵇ
tH $hV??ᵇ
tH $hV??ᵇ
;) `3a!d f|1
;) `3a!d f|1
{s qt/jp ]H*
{s qt/jp ]H*
P;V{ve?{I s@
P;V{ve?{I s@
K% E^; D&euX7 VIU3
K% E^; D&euX7 VIU3
M$ -ndn
M$ -ndn
HZIp7I7yZy
HZIp7I7yZy
&LLL_&_
&LLL_&_
/C[ t{*{ hSRS3SX3S-R /#m[m[m[=/j
/C[ t{*{ hSRS3SX3S-R /#m[m[m[=/j
4E4kE
4E4kE
Vj*m ?61 yr
Vj*m ?61 yr
TS1;*
y-SQF: g+T 9IMvyv
t
t
S
S
X
X
7eZ:egé
g!6YAAw aN c{6{{c6{{ +E{ TzV $L{L_6Ei
TS1;*
F=$W~TWk`$`~ ) @:0 WE_W8W{2}
9RRa[RR
t
f!DnRE:nd!L
9RRa[RR
pB
t
f!DnRE:nd!L
pB
U8U vY
t
f!DnRE:nd!L
U8U vY
;F; ~/P
t
f!DnRE:nd!L
;F; ~/P
0Y :9%
t
f!DnRE:nd!L
0Y :9%
7&7 iA6
S
f!DnRE:nd!L
7&7 iA6
PvP 3J6)J `DAN @Ih1N
S
f!DnRE:nd!L
PvP 3J6)J `DAN @Ih1N
z&u|P?u179 1Hl&1l^ ;fuF!! $L!FD_L_&F4H
S
f!DnRE:nd!L
z&u|P?u179 1Hl&1l^ ;fuF!! $L!FD_L_&F4H
or~Cr6rT,}? G 9*|z Z{7Z7ZEh$
O5 Ettᵃ
t
f!DnRE:nd!L
O5 Ettᵃ
N$N Hf
S
f!DnRE:nd!L
N$N Hf
,2, J[[
S
f!DnRE:nd!L
,2, J[[
7&7 iA6
S
f!DnRE:nd!L
7&7 iA6
ada :: v9\4 @`LLyLRF
X
f!DnRE:nd!L
ada :: v9\4 @`LLyLRF
e{s^{Q@
X
f!DnRE:nd!L
e{s^{Q@
BOP1EE 1)DNg4)4#NrE
X
f!DnRE:nd!L
BOP1EE 1)DNg4)4#NrE
u!uOs,,uo c ypeD=$FC,=,$ 7$,7
BOP1EE 1)DNg4)4#NrE
X
f!DnRE:nd!L
BOP1EE 1)DNg4)4#NrE
I2I @x, r[Y AoA r22
S
f!DnRE:nd!L
I2I @x, r[Y AoA r22
^r^p%$__Q h `Rwr iL% js8: x]dxAx2$)
)aIJDD #@#2OE@E$2Tq
X
f!DnRE:nd!L
)aIJDD #@#2OE@E$2Tq
L6E-H-6qkY4U A pxoqM[DM{
QYQ Dsu
t
f!DnRE:nd!L
QYQ Dsu
$UGgTJXGWWi ~ 2uwNxAy\yA
5@5 rv@4v
X
f!DnRE:nd!L
5@5 rv@4v
F=$W~TWk`$`~ ) @:0 WE_W8W{2}
aHu09H; W2W^(}6)mt h]-ZQS-l/Zo
t
f!DnRE:nd!L
aHu09H; W2W^(}6)mt h]-ZQS-l/Zo
QaCad dc*OMBnBJ
S
f!DnRE:nd!L
QaCad dc*OMBnBJ
,r,}cZ-&Z o gKnE@9;@q#a;ad qapq
L**)ZQoQ\u ;K)Zc qyTb{PP{Zq&y
X
f!DnRE:nd!L
L**)ZQoQ\u ;K)Zc qyTb{PP{Zq&y
\R:Hl+QwXwl=¹ / J/9 p ?j&~
wvy?-xE?j EIE ]\;wEE ^PAPAPCAP+A 68gWAWgWtrV
S
f!DnRE:nd!L
wvy?-xE?j EIE ]\;wEE ^PAPAPCAP+A 68gWAWgWtrV
L6E-H-6qkY4U A pxoqM[DM{
+m T\T@H d)0/0
t
f!DnRE:nd!L
+m T\T@H d)0/0
M_ #T )FGgG
t
f!DnRE:nd!L
M_ #T )FGgG
}pd# !04p4
t
f!DnRE:nd!L
}pd# !04p4
LD2-6G0 wc~o~
t
f!DnRE:nd!L
LD2-6G0 wc~o~
pL zMaM$n$
t
f!DnRE:nd!L
pL zMaM$n$
~0 iM||
t
f!DnRE:nd!L
~0 iM||
D= *^@@
t
f!DnRE:nd!L
D= *^@@
BF ?[ss
t
f!DnRE:nd!L
BF ?[ss
a) Q`^Q9|`
t
f!DnRE:nd!L
a) Q`^Q9|`
b7 yqv
t
f!DnRE:nd!L
b7 yqv
5` !oo
t
f!DnRE:nd!L
5` !oo
sQ :x:
t
f!DnRE:nd!L
sQ :x:
hIFc #pp
S
f!DnRE:nd!L
hIFc #pp
|~ U=P8P Q8HCUH:-Q4UH8 87C!rKN/!7qi
X
f!DnRE:nd!L
|~ U=P8P Q8HCUH:-Q4UH8 87C!rKN/!7qi
$UGgTJXGWWi ~ 2uwNxAy\yA
C{ (t9S* #B]# y/VQV
t
f!DnRE:nd!L
C{ (t9S* #B]# y/VQV
`S\@\ Gom6 s*m\1QPZ^1*m
X
f!DnRE:nd!L
`S\@\ Gom6 s*m\1QPZ^1*m
$bKu`t#$² * %Do; cK,cacjXJ
Q_ A*Y \?K&| yS3&^8
X
f!DnRE:nd!L
Q_ A*Y \?K&| yS3&^8
S#ShL,,2H @ $)BK |k6|Y|Q6)
Q_ A*Y \?K&| yS3&^8
X
f!DnRE:nd!L
Q_ A*Y \?K&| yS3&^8
R5rL&8Qz³ P !l^iE//%
Q_ A*Y \?K&| yS3&^8
X
f!DnRE:nd!L
Q_ A*Y \?K&| yS3&^8
)#)o&39m 1 %5M~ L2p
BD[I! T}{zuA
X
f!DnRE:nd!L
BD[I! T}{zuA
b0bWeeh⁴ V @%+~X_1uP
H{{Vzsz
S
f!DnRE:nd!L
H{{Vzsz
~0 iM||
S
f!DnRE:nd!L
~0 iM||
Ib|w}OOG d 1H IEgbhna*hEn[
GF /G|3|ᵇ
S
f!DnRE:nd!L
GF /G|3|ᵇ
=%Rsqqc (hvyvᵇ
S
f!DnRE:nd!L
=%Rsqqc (hvyvᵇ
+Vb ?CoUoᵇ
S
f!DnRE:nd!L
+Vb ?CoUoᵇ
tH $hV??ᵇ
S
f!DnRE:nd!L
tH $hV??ᵇ
PX_r,XaX#X5⁵ G #n$mJJLb( %#+~
;) `3a!d f|1
S
f!DnRE:nd!L
;) `3a!d f|1
{s qt/jp ]H*
t
f!DnRE:nd!L
{s qt/jp ]H*
h%h}gGG4 1 =tZy=gb@y
P;V{ve?{I s@
S
f!DnRE:nd!L
P;V{ve?{I s@
W[WL;xW5x z r3:] mTWmrm2_x
BD[I! T}{zuA
X
f!DnRE:nd!L
BD[I! T}{zuA
?f?1}/8L8 ) wWJL E}^EhEyfD
BD[I! T}{zuA
X
f!DnRE:nd!L
BD[I! T}{zuA
R4RPU_?4_ n |;YV $@$Ul@N
BD[I! T}{zuA
X
f!DnRE:nd!L
BD[I! T}{zuA
vUv8{LYo{ N vJ2ζ V]kVXV?f+
BD[I! T}{zuA
X
f!DnRE:nd!L
BD[I! T}{zuA
&M&XHCd&& p k!1G}ee)-
BD[I! T}{zuA
X
f!DnRE:nd!L
BD[I! T}{zuA
Z{4-#{T-9 l BT0B Mm^ 5ue5U5+a{
K% E^; D&euX7 VIU3
t
f!DnRE:nd!L
K% E^; D&euX7 VIU3
]aH9a5a;aB⁶ : 4rry 7 o@T
M$ -ndn
t
f!DnRE:nd!L
M$ -ndn
HZIp7I7yZy
t
f!DnRE:nd!L
HZIp7I7yZy
&LLL_&_
t
f!DnRE:nd!L
&LLL_&_
/C[ t{*{ hSRS3SX3S-R /#m[m[m[=/j
X
f!DnRE:nd!L
/C[ t{*{ hSRS3SX3S-R /#m[m[m[=/j
f;-l%Vf;JVG⁶ $ `S}lUM [ NLg
4E4kE
X
f!DnRE:nd!L
4E4kE
BMB]HY#P + pA&&e S!{Z!S2
BD[I! T}{zuA
X
f!DnRE:nd!L
BD[I! T}{zuA
RqR%R/--[ H 5%b_ P rI?W1 cw;s
Vj*m ?61 yr
X
f!DnRE:nd!L
Vj*m ?61 yr
v9vNv!AWW ~ i%8k N jk8``
BD[I! T}{zuA
X
f!DnRE:nd!L
BD[I! T}{zuA

À 0nq\]q P2 ~iûe )Z)f

XAmgen collaboration; BeiGene has China commercial rights. SEnsem collaboration; BeiGene has global rights. tDualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. \Leads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. SZymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. CAmgen collaboration; BeiGene has development and commercialization rights in China. #In combination with Zanubrutinib. 2May include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.

Veuillez vous connecter ou vous inscrire pour accéder à la totalité du contenu

S’inscrire

Déjà inscrit(e) ?  Se connecter